📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-10-09 10:36
6 analysed today
FollowTelegram
6
Today
149,957
All-time analysed
42,989
Positive
6,669
Negative
91,589
Neutral
8,642
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
7 announcements match the current filters (relevance ≥ 5).
ICL Fincorp & Promoters Allotted 75.99 Lakh Shares via Rights Issue in Salem Erode Investments
Salem Erode Investments received a SAST Reg. 29(2) disclosure regarding the allotment of 75,99,140 equity shares via a Rights Issue to ICL Fincorp Limited, Mr. K G Anilkumar, and Ms. Umadevi Anilkumar. Prior to this issue, promoter holding stood at 75.0%, and the company carries a small market cap of approximately Rs 30 Cr. This equity issuance expands the equity base for the loss-making microcap NBFC, which reported TTM net losses of Rs -5 Cr on TTM revenue of Rs 3 Cr.
Confidence: HIGH
What changed75,99,140 equity shares were issued and allotted to promoter entities/ICL Fincorp under a Rights Issue.
Why it mattersThe Rights Issue brings in equity capital to support net worth, which stands at Rs 15 Cr amid ongoing quarterly net losses.
Shares allotted via Rights Issue: 75,99,140Market capitalization (approx.): Rs 30 CrTTM PAT: Rs -5 Cr
📅 Short termTrading reaction may remain muted as this reflects the formal acquisition disclosure following the rights allotment process.
📈 Long termCapital infusion provides a cushion for the balance sheet, but long-term value creation depends on reversing ongoing operational losses.
⚠ Risk flags
- Persistent operational losses (TTM PAT Rs -5 Cr)
- Equity dilution from new share issuance
Key Highlights
Allotment of 75,99,140 equity shares via Rights Issue
Acquirers include ICL Fincorp Limited, Mr. K G Anilkumar, and Ms. Umadevi Anilkumar
Disclosure filed under Regulation 29(2) of SEBI (SAST) Regulations, 2011
Notification dated October 08, 2026, submitted to BSE
👀 What to Watch
Track the updated shareholding pattern and total post-issue equity capital to assess dilution and post-rights promoter shareholding percentage.
Salem Erode Investments Approves ₹22.93 Cr Rights Issue at ₹20/Share (1:1 Ratio)
Salem Erode Investments Ltd has approved the terms of its Rights Issue to raise up to ₹2,293.10 Lakhs (₹22.93 Cr). The company will issue up to 1,14,65,520 equity shares at a price of ₹20 per share (face value ₹1 plus ₹19 premium) on a 1:1 ratio. The fundraise represents approximately 57% of the company's current market cap of ₹40 Cr and over 150% of its net worth (₹15 Cr). The record date to determine eligible shareholders is September 03, 2026, with the issue scheduled to open on September 15, 2026, and close on September 25, 2026.
Confidence: HIGH
What changedThe Board has finalised the pricing (₹20/share), ratio (1:1), size (₹22.93 Cr), and full timetable for the proposed Rights Issue.
Why it mattersThe ₹22.93 Cr capital infusion is massive relative to the company's ₹15 Cr net worth, but full subscription will double the existing equity base, causing 50% dilution for non-participating shareholders.
Issue Size: ₹2,293.10 LakhsIssue Price: ₹20 per shareRights Ratio: 1:1Issue vs Market Cap: ~57%Record Date: September 03, 2026
📅 Short termEx-rights price adjustment will take place around September 03, 2026, and trading in Rights Entitlements (RE) will occur from September 15 to September 21, 2026.
📈 Long termThe capital injection will expand the equity base of the NBFC, but sustained turnaround depends on deploying funds profitably after posting consecutive annual net losses (FY26 loss of ₹4.85 Cr).
⚠ Risk flags
- Substantial equity dilution (100% expansion in share count)
- Ongoing operational losses (TTM PAT of ₹-5 Cr on TTM revenue of ₹3 Cr)
Key Highlights
Board approved Rights Issue of up to 1,14,65,520 equity shares aggregating up to ₹2,293.10 Lakhs (₹22.93 Cr)
Issue price fixed at ₹20 per share (₹1 face value + ₹19 premium), offered in a 1:1 ratio
Record date set for Thursday, September 03, 2026
Issue opens on September 15, 2026, and closes on September 25, 2026
On-market renunciation window is open until September 21, 2026
👀 What to Watch
Existing shareholders should track the Record Date of September 03, 2026, and decide whether to subscribe or renounce their rights entitlements between September 15 and September 21, 2026.
Rs 5 Cr TTM Loss: Salem Erode Investments approves Q1 FY27 results
Salem Erode Investments approved its standalone financial results for the quarter ended June 30, 2026, on August 13, 2026. The company is a micro-cap NBFC with a market capitalization of Rs 41 Cr and a net worth of Rs 15 Cr. It remains in a difficult financial position, with a TTM net loss of Rs 5 Cr exceeding its TTM revenue of Rs 4 Cr. Revenue has been declining sequentially, from Rs 1.1 Cr in June 2025 to Rs 0.73 Cr in March 2026. Investors should monitor the full Q1 results for any signs of narrowing losses or operational improvements.
Confidence: HIGH
What changedThe company's board approved the unaudited financial results for the first quarter of the 2026-27 fiscal year.
Why it mattersAs a loss-making micro-cap, these results are vital to determine if the company can sustain its operations without further eroding its Rs 15 Cr net worth.
TTM Net Loss: Rs 5 CrTTM Revenue: Rs 4 CrNet Worth: Rs 15 CrMarket Cap: Rs 41 CrPromoter Holding: 75.0%
📅 Short termNeutral; the market is likely to wait for the full data release to see if the loss-making trend has reversed.
📈 Long termThe company faces structural challenges with a TTM loss exceeding its annual revenue; long-term viability depends on a significant turnaround in the lending business.
⚠ Risk flags
- Persistent net losses
- Declining revenue trajectory
- High TTM loss relative to net worth (~33%)
Key Highlights
The board meeting to approve results concluded at 04.25 p.m. IST on August 13, 2026.
The company reported a TTM Net Loss of Rs 5 Cr against a TTM Revenue of Rs 4 Cr.
Net Worth stands at Rs 15 Cr, while the Market Capitalization is Rs 41 Cr.
Promoter holding is stable at 75.0% as of the June 2026 quarter.
👀 What to Watch
Monitor the detailed financial notes for any recovery in interest income or reduction in provisioning, which are essential for the company to reach break-even.
Salem Erode Investments Approves Q1 FY27 Results; Board Meeting Concludes
Salem Erode Investments approved its unaudited standalone financial results for the quarter ended June 30, 2026, in a board meeting held on August 13, 2026. The company, a micro-cap NBFC with a market capitalization of Rs 41 Cr, continues to operate under financial pressure, having reported a TTM net loss of Rs 5 Cr. The statutory auditor issued a limited review report with no material qualifications. Given the company's small TTM revenue of Rs 4 Cr and negative EPS, these results are critical for assessing its ongoing solvency.
Confidence: HIGH
What changedThe company has completed its regulatory requirement of approving and disclosing financial results for the first quarter of FY27.
Why it mattersFor a micro-cap NBFC with significant losses relative to its revenue and net worth, quarterly results are the primary indicator of whether the business can achieve a turnaround or if capital erosion will continue.
TTM Net Profit: Rs -5 CrTTM Revenue: Rs 4 CrNet Worth: Rs 15 CrMarket Cap: Rs 41 CrPromoter Holding: 75.0%
📅 Short termThe stock may remain range-bound as the market processes the continued loss-making status of the company.
📈 Long termThe long-term outlook is constrained by the company's small scale and consistent losses; a structural turnaround in the loan book or margins is required.
⚠ Risk flags
- Consistent net losses (Rs -4.85 Cr in FY26)
- Small scale of operations (TTM Revenue Rs 4 Cr)
- Negative TTM EPS of Rs -4.23
Key Highlights
Board meeting held on August 13, 2026, commenced at 02:00 p.m. and concluded at 04:25 p.m.
Unaudited standalone financial results for the quarter ended June 30, 2026, were approved.
Company reported a TTM net loss of Rs 5 Cr against a TTM revenue of only Rs 4 Cr.
Net worth stands at Rs 15 Cr as per the latest available financial context.
Promoter holding remains stable at 75.0% as of the June 2026 quarter.
👀 What to Watch
Investors should examine the full quarterly P&L statement for any signs of narrowing losses or operational improvements, as the company has been loss-making for at least four consecutive quarters.
₹3.69 Cr NCD Allotment: Salem Erode Investments Raises Funds via Private Placement
Salem Erode Investments has approved the allotment of 36,950 unlisted secured redeemable Non-Convertible Debentures (NCDs) at a face value of ₹1,000 each, totaling ₹3.695 Cr. A significant portion of this issue, amounting to ₹3 Cr (81% of the total), was allotted to its holding company, ICL Fincorp Limited. This fundraise is substantial for the company, representing approximately 92% of its TTM revenue of ₹4 Cr and 24.6% of its net worth. The company remains loss-making, with a net loss of ₹4.85 Cr reported for FY26.
Confidence: HIGH
What changedThe company has issued new unlisted debt to raise ₹3.695 Cr, primarily through its parent company.
Why it mattersFor a small-cap NBFC with a ₹41 Cr market cap and ongoing losses, this parent-backed liquidity is critical for maintaining operations, though the debt is unlisted and secured.
Total Allotment Value: ₹3,69,50,000Parent Company Subscription: ₹3,00,00,000Fundraise vs TTM Revenue: ~92.4%Fundraise vs Net Worth: ~24.6%Face Value per NCD: ₹1,000
📅 Short termThe news indicates immediate liquidity support from the parent company, which may provide some stability to the stock in the short term despite the company's loss-making status.
📈 Long termThe long-term impact depends on the company's ability to turn profitable; currently, the reliance on parent-funded debt highlights a weak independent cash-flow position.
⚠ Risk flags
- Related-party transaction (81% funded by parent)
- Unlisted debt instruments
- Persistent net losses (₹-5 Cr TTM)
- Small-cap liquidity risk
Key Highlights
Allotment of 36,950 Unlisted Secured Redeemable NCDs at ₹1,000 face value each.
Total capital raised amounts to ₹3,69,50,000 (₹3.695 Cr).
₹3,00,00,000 (₹3 Cr) of the allotment was subscribed by the holding company, ICL Fincorp Limited.
The fundraise magnitude is approximately 92.4% of the company's TTM revenue of ₹4 Cr.
The allotment was approved by the Debenture and Bond Committee in a meeting on August 01, 2026.
👀 What to Watch
Investors should monitor the company's upcoming quarterly results to see if this capital infusion helps improve interest income and mitigate the persistent net losses, which stood at ₹1.4 Cr in the March 2026 quarter.
Rs 4 Cr Fundraise via Unlisted Secured NCDs Approved by Salem Erode Investments
Salem Erode Investments has approved raising Rs 4 crore through the private placement of 40,000 unlisted secured Non-Convertible Debentures (NCDs). This fundraise is highly material, representing 100% of the company's TTM revenue of Rs 4 crore and approximately 26.7% of its net worth. The NCDs offer a 12% coupon for a 36-month tenure or a principal-doubling option over 68 months. The debt is secured against the company's current assets and gold loan receivables.
Confidence: HIGH
What changedThe company has authorized a fresh debt raise of Rs 4 crore through unlisted secured NCDs on a private placement basis.
Why it mattersFor a micro-cap NBFC with limited revenue, this fundraise provides essential liquidity for lending; however, the 12% interest cost adds significant pressure to an already loss-making bottom line.
Issue Size: Rs 4.00 CrIssue vs TTM Revenue: 100%Issue vs Net Worth: 26.7%Coupon Rate: 12.00%Max Tenure: 68 months
📅 Short termNeutral; the market will likely wait for evidence of successful fund deployment and its impact on interest income.
📈 Long termThe company must significantly scale its loan book to service this 12% debt, as current operations are not generating enough profit to cover existing costs.
⚠ Risk flags
- Loss-making status (TTM PAT -Rs 5 Cr)
- High cost of debt (12% coupon)
- Unlisted nature of the NCDs
- Small scale of operations
Key Highlights
Total issue size of Rs 4.00 crore via 40,000 NCDs with a face value of Rs 1,000 each
Coupon rate of 12.00% per annum offered for the 36-month monthly interest scheme
Cumulative scheme available for 68 months which doubles the principal amount
Minimum security cover of 100% provided against current assets and gold loan receivables
Allotment to be completed within 30 days from the receipt of application money
👀 What to Watch
Monitor the company's upcoming quarterly results to see if this capital infusion helps reverse the current trend of losses (TTM PAT of -Rs 5 crore).
Board Meeting on July 23 to Consider Fundraise via Secured NCDs
Salem Erode Investments Ltd has scheduled a board meeting for July 23, 2026, to consider raising funds through the private placement of Secured Redeemable Non-Convertible Debentures (NCDs). The company is a micro-cap NBFC with a market capitalization of ₹44 Cr and is currently loss-making, reporting a TTM PAT of -₹5 Cr. With a net worth of only ₹15 Cr, the size of the debt issuance will be highly material to its capital structure. Investors should watch for the specific quantum and the interest rate (coupon) offered.
Confidence: HIGH
What changedThe company is seeking to raise debt capital via NCDs.
Why it mattersAs a loss-making NBFC (TTM PAT -₹5 Cr), additional capital is likely needed for liquidity or to expand its loan book, though the cost of debt will be critical.
Board Meeting Date: July 23, 2026TTM Revenue: ₹4 CrTTM PAT: -₹5 CrNet Worth: ₹15 CrMarket Cap: ₹44 Cr
📅 Short termMarket will focus on the fundraise size and terms following the July 23 meeting.
📈 Long termStructural impact depends on whether the company can pivot to profitability using the new capital.
⚠ Risk flags
- Loss-making operations
- Small scale of business
- High debt-servicing risk for micro-caps
Key Highlights
Board meeting date set for July 23, 2026, to approve fundraise
Instrument type: Secured Redeemable Non-Convertible Debentures (NCDs)
Method: Private Placement basis
Company TTM Revenue stands at ₹4 Cr against a Net Worth of ₹15 Cr
👀 What to Watch
Watch for the post-meeting disclosure on July 23 regarding the total amount to be raised and the cost of borrowing.
